Sildenafil (Viagra): Ratiopharm "levanta"...vuelo.

La EMEA se abre a Ratiopharm...

On 22 October 2009 the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion,** recommending to grant a marketing authorisation for the medicinal product Sildenafil ratiopharm, 25 mg, 50 mg and 100 mg, film-coated tablets intended for the treatment of erectile dysfunction. The applicant for this medicinal product is ratiopharm GmbH.


The active substance of Sildenafil ratiopharm is sildenafil, which belongs to the group of substances used in the treatment of erectile dysfunction (G04BE03).


Sildenafil ratiopharm is a generic of Viagra which has been authorised in the EU since 14 September 1998. Studies have demonstrated the satisfactory quality of Sildenafil ratiopharm, and its bioequivalence with Viagra. A question-and-answer document on generic medicines can be found here.

Más...